RESEQUENCING THE VARIABLE HUMAN GENOME IN SPORADIC ALS: A NECESSARY PRELUDE TO
RESEQUENCING THE VARIABLE HUMAN GENOME IN SPORADIC ALS: A NECESSARY PRELUDE TO
批准号:
7606662
负责人:
TAHSEEN MOZAFFAR
金额:
$1.01万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30
关键词:
Amyotrophic Lateral SclerosisBlood specimenComputer Retrieval of Information on Scientific Projects DatabaseDNA ResequencingDiseaseDrug Delivery SystemsFamily history ofFundingGenetic MaterialsGrantHuman GenomeInstitutionMotor NeuronsMuscle WeaknessPatientsPersonsResearchResearch PersonnelResourcesSourceTargeted ResearchUnited States National Institutes of Healthnervous system disorder
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Amyotrophic lateral sclerosis and related motor neuron disorders are neurological diseases that cause muscle weakness. In most patients, the cause is unknown and no effective treatment exists. To study possible causes in a person's genetic material, the Western ALS Consortium [WALS] researchers need blood samples and some basic health-related medical and family history information from patients. This study is collecting the blood samples and information for targeted research into the causes of ALS aiming towards targeted drug treatment in ALS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Influence of NT5c1A antibodies on disease progression, clinical phenotype and blood and muscle biomarkers in sporadic Inclusion Body Myositis - A prospective evaluation
-
批准号:10596154
-
项目类别:
-
资助金额:$96.03万
-
财政年份:2021
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
Influence of NT5c1A antibodies on disease progression, clinical phenotype and blood and muscle biomarkers in sporadic Inclusion Body Myositis - A prospective evaluation
-
批准号:10381454
-
项目类别:
-
资助金额:$115.9万
-
财政年份:2021
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
UCI-NEXT, a NeuroNEXT site
-
批准号:10192846
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2018
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
UCI-NEXT, a NeuroNEXT site
-
批准号:9983184
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2018
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
UCI-NEXT, a NeuroNEXT site
-
批准号:10407606
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2018
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
A MULTICENTER STUDY FOR THE VALIDATION OF ALS BIOMARKERS
-
批准号:8166934
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2009
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
OPEN LABEL EXTENSION OF PROTOCOL AALS-001 (#AALS-001-OL) - ARIMOCLOMOL IN AMY
-
批准号:7725027
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2007
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
A MULTI-CENTER, PHASE III, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, CLINIC
-
批准号:7724999
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2007
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
COMBINATION DRUG SELECTION TRIAL IN AMYOTROPHIC LATERAL SCLEROSIS
-
批准号:7725029
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2007
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
A MULTICENTER, DOSE RANGING SAFETY AND PHARMACOKINETICS STUDY OF ARIMOCLOMOL IN)
-
批准号:7606647
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2006
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
COMBINATION DRUG SELECTION TRIAL IN AMYOTROPHIC LATERAL SCLEROSIS
-
批准号:7606663
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2006
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
OPEN LABEL EXTENSION OF PROTOCOL AALS-001 (#AALS-001-OL) - ARIMOCLOMOL IN AMY
-
批准号:7606659
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2006
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
AMYOTROPHIC LATERAL SCLEROSIS RESEARCH GROUP [ALS RG] COLLECTION OF DATA AND BI
-
批准号:7606658
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2006
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
A MULTI-CENTER, PHASE III, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, CLINIC
-
批准号:7606629
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2006
-
负责人:TAHSEEN MOZAFFAR
-
依托单位:
海外基金